CALEB ROWE: Open Payments
NPI 1538531868 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,882 in 149 payments from 21 companies in 2025. Trend: 2023 $1,207 · 2024 $2,133 · 2025 $2,882
Food & beverage: $2,707Education: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $683 |
| Janssen Biotech, Inc. | 13 | $402 |
| Galderma Laboratories, L.P. | 21 | $355 |
| Novartis Pharmaceuticals Corporation | 14 | $293 |
| GENZYME CORPORATION | 7 | $268 |
| Arcutis Biotherapeutics, Inc. | 15 | $151 |
| LEO Pharma Inc. | 6 | $135 |
| Regeneron Healthcare Solutions, Inc. | 4 | $110 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $74 |
| Amgen Inc. | 3 | $49 |
Products named: TREMFYA, DUPIXENT, RINVOQ, NEMLUVIO, SKYRIZI, Zoryve, COSENTYX, ADBRY.
Industry payments across KY — which companies pay providers there.
